Allogeneic bone marrow transplantation for acute leukemia in adults

被引：0

作者：

Masszi, T ^{[1
]}

Reményi, P ^{[1
]}

Kriván, G ^{[1
]}

Goda, V ^{[1
]}

Réti, M ^{[1
]}

机构：

[1] St Laszlo Hosp, BMT Unit, H-1097 Budapest, Hungary

来源：

BONE MARROW TRANSPLANTATION | 1998年 / 22卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

From September 1993 to August 1997, 24 consecutive adult acute leukemia patients (20 AML and 4 ALL) received allogeneic bone marrow transplant (21 sibling, 1 twin, 2 MUD). The probability of 3 year leukemia free survival is 19/24 (79%), the transplant related mortality is 2/24(8%), the relapse rate is 3/24 (13%), The median follow up period is 34 months (range 7-51), Three AML patients with high probability of TRM received a special radiation-free conditioning regimen (mitobronitol/cytarabine/cyclophosphamide) originally described by Kelemen ct al in CML patients for decreasing transplant related complications, All the three patients are alive and disease free over 3 years.

引用

页码：S77 / S79

页数：3

共 7 条

[1]

BLAISE D, 1992, BLOOD, V79, P2578

[2]

Frassoni F, 1996, BONE MARROW TRANSPL, V17, P13

[3]

KELEMEN E, 1993, LEUKEMIA, V7, P939

[4]

LABAR B, 1996, BONE MARROW TRANSPL, V16, P1009

[5]

MASSZI T, 1996, BONE MARROW TRANSPL, V17, pS81

[6]

Porter DL, 1996, BONE MARROW TRANSPL, V18, P975

[7] AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION COMPARED WITH INTENSIVE CHEMOTHERAPY IN ACUTE MYELOGENOUS LEUKEMIA [J].

ZITTOUN, RA ;

MANDELLI, F ;

WILLEMZE, R ;

DEWITTE, T ;

LABAR, B ;

RESEGOTTI, L ;

LEONI, F ;

DAMASIO, E ;

VISANI, G ;

PAPA, G ;

CARONIA, F ;

HAYAT, M ;

STRYCKMANS, P ;

ROTOLI, B ;

LEONI, P ;

PEETERMANS, ME ;

DARDENNE, M ;

VEGNA, ML ;

PETTI, MC ;

SOLBU, G ;

SUCIU, S .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (04) :217-223

← 1 →